4//SEC Filing
Connelly Stephen 4
Accession 0001415889-25-004762
CIK 0001746466other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 7:43 PM ET
Size
29.5 KB
Accession
0001415889-25-004762
Insider Transaction Report
Form 4
Connelly Stephen
DirectorPresident and CSO
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2025-02-14−175,000→ 0 totalExercise: $1.06Exp: 2033-01-02→ Common Stock (175,000 underlying) - Award
Employee Stock Option (right to buy)
2025-02-14+90,000→ 90,000 totalExercise: $0.79Exp: 2029-02-12→ Common Stock (90,000 underlying) - Award
Employee Stock Option (right to buy)
2025-02-14+52,500→ 52,500 totalExercise: $0.79Exp: 2029-12-09→ Common Stock (52,500 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2025-02-14−100,000→ 0 totalExercise: $5.03Exp: 2031-01-03→ Common Stock (100,000 underlying) - Award
Employee Stock Option (right to buy)
2025-02-14+125,000→ 125,000 totalExercise: $0.79Exp: 2032-01-18→ Common Stock (125,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2025-02-14−90,000→ 0 totalExercise: $7.16Exp: 2029-02-12→ Common Stock (90,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2025-02-14−52,500→ 0 totalExercise: $4.75Exp: 2029-12-09→ Common Stock (52,500 underlying) - Award
Employee Stock Option (right to buy)
2025-02-14+100,000→ 100,000 totalExercise: $0.79Exp: 2031-01-03→ Common Stock (100,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2025-02-14−42,534→ 0 totalExercise: $2.80Exp: 2030-05-18→ Common Stock (42,534 underlying) - Award
Employee Stock Option (right to buy)
2025-02-14+175,000→ 175,000 totalExercise: $0.79Exp: 2033-01-02→ Common Stock (175,000 underlying) - Award
Employee Stock Option (right to buy)
2025-02-14+42,534→ 42,534 totalExercise: $0.79Exp: 2030-05-18→ Common Stock (42,534 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2025-02-14−125,000→ 0 totalExercise: $3.86Exp: 2032-01-18→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
- [F2]On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.
Documents
Issuer
Equillium, Inc.
CIK 0001746466
Entity typeother
Related Parties
1- filerCIK 0001746808
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 7:43 PM ET
- Size
- 29.5 KB